Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax. SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax.
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.07 | -5.69105691057 | 1.23 | 1.24 | 1.14 | 551311 | 1.19827755 | CS |
| 4 | -0.12 | -9.375 | 1.28 | 1.31 | 1.07 | 629106 | 1.20012559 | CS |
| 12 | -0.05 | -4.13223140496 | 1.21 | 1.42 | 1.07 | 519003 | 1.24089499 | CS |
| 26 | -0.17 | -12.7819548872 | 1.33 | 1.7 | 0.81 | 748636 | 1.26157155 | CS |
| 52 | 0.1601 | 16.0116011601 | 0.9999 | 1.72 | 0.4986 | 1020027 | 1.11686255 | CS |
| 156 | -8.09 | -87.4594594595 | 9.25 | 9.78 | 0.4986 | 512648 | 1.67712833 | CS |
| 260 | 1.018 | 716.901408451 | 0.142 | 19.38 | 0.1258 | 855804 | 5.35958401 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
